Human zinc finger protein 161, a novel transcriptional activator of the dopamine transporter

Biochemical and Biophysical Research Communications

Volumn 313, Issue 4, 2004, Pages 969-976

  Lee, Ki Hwan ^a   Kwak, Young Don ^b   Kim, Dong Hwan ^a   Chang, Mi Yoon ^a   Lee, Young Seek ^c   Lee, Yong Sung ^a  

^a Hanyang University   (South Korea)

^b UNIVERSITY OF ILLINOIS   (United States)

^c Hanyang University   (South Korea)

Author keywords

Dopamine transporter; Promoter assay; Transcription regulation; Yeast one hybrid; ZFP161

Indexed keywords

DOPAMINE TRANSPORTER; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE ACTIVITY; GENE DELETION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; RAT; TRANSCRIPTION REGULATION;

EID: 0347989416     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.183     Document Type: Article

References (33)

1. Nirenberg M.J., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16:1996;436-447.
2. Giros B., Caron M.G. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14:1993;43-49.
3. Bannon M.J., Granneman J.G., Kapatos G. The dopamine transporter. Bloom F.E., Kupfer D.J. Psychopharmacology-Fourth Generation of Progress. 1995;179-188 Raven Press, New York.
4. Grace A.A. The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend. 37:1995;111-129.
5. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. USA. 95:1998;4029-4034.
6. - neurotransmitter transporters. J. Neurochem. 71:1998;1785-1803.
7. ′ -flanking sequence elements and gene structures Mol. Brain Res. 30:1995;327-335.
8. Giros B., El Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:1992;383-390.
9. Kawarai T., KawaKami H., Yamamura Y., Nakamura S. Structure and organization of the gene encoding human dopamine transporter. Gene. 195:1997;11-18.
10. Kouzmenko A.P., Pereira A.M., Singh B.S. Intronic sequences are involved in neuronal targeting of human dopamine transporter gene expression. Biochem. Biophys. Res. Commun. 240:1997;807-811.
11. ′ -flanking region of the human dopamine transporter gene Mol. Brain Res. 74:1999;167-174.
12. Perrone-Capano C., Tino A., Amadoro G., Pernas-Alonso R., di Porzio U. Dopamine transporter gene expression in rat mesencephalic dopaminergic neurons is increased by direct interaction with target striatal cells in vitro. Brain Res. Mol. Brain Res. 39:1996;160-166.
13. Lorang D., Amara S.G., Simerly R.B. Cell-type-specific expression of catecholamine transporters in the rat brain. J. Neurosci. 14:1994;4903-4914.
14. Lee K.H., Kim H.S., Jeong H.S., Lee Y.S. Chaperonin GroESL mediates the protein folding of human liver mitochondrial aldehyde dehydrogenase in Escherichia coli. Biochem. Biophys. Res. Commun. 298:2002;216-224.
15. Lee S.H., Chang M.Y., Lee K.H., Park B.S., Lee Y.S., Chin H.R., Lee Y.S. Importance of valine at position 152 for the substrate transport and 2β-carbomethoxy-3β-(4-fluorophenyl)tropane binding of dopamine transporter. Mol. Pharmacol. 57:2000;883-889.
16. Sobek-Klocke I., Disque-Kochem C., Ronsik M., Klocke R., Jockusch H., Breuning A., Ponstingl H., Rojas K., Overhauser J., Eichenlaub-Ritter U. The human gene ZFP161 on 18p11.21-pter encodes a putative c-myc repressor and is homologous to murine ZFP161 (chr 17) and ZFP161-rs1 (X chr). Genomics. 43:1997;156-164.
17. Sugiura K., Muro Y., Nagai Y., Kaminoto T., Wakabayashi T., Ohashi M., Hagiwara M. Expression cloning and intracellular localization of a human ZF5 homologue. Biochim. Biophys. Acta. 1352:1997;23-26.
18. Numoto M., Niwa O., Kaplan J., Wong K.K., Merrell K., Kamiya K., Yanagihara K., Calame K. Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins. Nucleic Acids Res. 21:1993;3767-3775.
19. Kaplan J., Calame K. The ZiN/POZ domain of ZF5 is required for both transcriptional activation and repression. Nucleic Acids Res. 25:1997;1108-1116.
20. Numoto M., Yokoro K., Yanagihar K., Kamiya K., Niwa O. Over-expressed ZF5 gene product, a c-myc-binding protein related to GL1-Kruppel protein, has a growth suppressive activity in mouse cell lines. Jpn. J. Cancer Res. 86:1995;277-283.
21. Cathomen T., Stracker T.H., Gilbert L.B., Weitzman M.D. A genetic screen identifies a cellular regulator of adeno-associated virus. Proc. Natl. Acad. Sci. USA. 98:2001;14991-14996.
22. Numoto M., Yokoro K., Yasuda S., Yanagihar K., Niwa O. Detection of mouse skeletal muscle-specific product, which includes ZF5 zinc fingers and a VP16 acidic domain, by reverse transcriptase PCR. Biochem. Biophys. Res. Commun. 236:1997;20-25.
23. Bardwell V.J., Treisman R. The POZ domain: a conserved protein protein interaction motif. Genes Dev. 8:1994;1664-1667.
24. Albagli O., Dhordain P., Deweindt C., Lecocq G., Leprince D. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell. Growth Differ. 6:1995;1193-1198.
25. Dhordain P., Albagli O., Lin R.J., Ansieau S., Quief S., Leutz A., Kerckaert J.P., Evans R.M., Leprince D. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl. Acad. Sci. USA. 94:1997;10762-10767.
26. Huynh K.D., Fischle W., Verdin E., Bardwell V.J. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 14:2000;1810-1823.
27. Suske G. The Sp-family of transcription factors. Gene. 238:1999;291-300.
28. Lee D.K., Suh D., Edenberg H.J., Hur M.W. POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1. J. Biol. Chem. 277:2002;26761-26768.
29. Obata T., Yanagidani A., Yokoro K., Numoto M., Yamamoto S. Analysis of the consensus binding sequence and the DNA-binding domain of ZF5. Biochem. Biophys. Res. Commun. 255:1999;528-534.
30. O'Brien T., Wilkins R.C., Giardina C., Lis J.T. Distribution of GAGA protein on Drosophila genes in vivo. Genes Dev. 9:1995;1098-1110.
31. Tsukiyama T., Becker P.B., Wu C. ATP-dependent nucleosome disruption at a heat-shock promoter mediated by binding of GAGA transcription factor. Nature. 367:1994;525-532.
32. Kalenik J.L., Chen D., Bradley M.E., Chen S.J., Lee T.C. Yeast two-hybrid cloning of a novel zinc finger protein that interacts with the multifunctional transcription factor YY1. Nucleic Acids Res. 25:1997;843-849.
33. Sawa C., Yoshikawa T., Matsuda-Suzuki F., Delehouzee S., Goto M., Watanabe H., Sawada J., Kataoka K., Handa H. YEAF1/RYBP and YAF-2 are functionally distinct members of a cofactor family for the YY1 and E4TF1/hGABP transcription factors. J. Biol. Chem. 277:2002;22484-22490.